These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 36835588)

  • 1. Application Progress of the Single Domain Antibody in Medicine.
    Tang H; Gao Y; Han J
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction to heavy chain antibodies and derived Nanobodies.
    Vincke C; Muyldermans S
    Methods Mol Biol; 2012; 911():15-26. PubMed ID: 22886243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanobodies as efficient drug-carriers: Progress and trends in chemotherapy.
    Panikar SS; Banu N; Haramati J; Del Toro-Arreola S; Riera Leal A; Salas P
    J Control Release; 2021 Jun; 334():389-412. PubMed ID: 33964364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single Domain Antibody application in bacterial infection diagnosis and neutralization.
    Qin Q; Liu H; He W; Guo Y; Zhang J; She J; Zheng F; Zhang S; Muyldermans S; Wen Y
    Front Immunol; 2022; 13():1014377. PubMed ID: 36248787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies.
    Romao E; Morales-Yanez F; Hu Y; Crauwels M; De Pauw P; Hassanzadeh GG; Devoogdt N; Ackaert C; Vincke C; Muyldermans S
    Curr Pharm Des; 2016; 22(43):6500-6518. PubMed ID: 27669966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.
    Bannas P; Hambach J; Koch-Nolte F
    Front Immunol; 2017; 8():1603. PubMed ID: 29213270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single domain antibody: Development and application in biotechnology and biopharma.
    Yu T; Zheng F; He W; Muyldermans S; Wen Y
    Immunol Rev; 2024 Nov; 328(1):98-112. PubMed ID: 39166870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoreaction of a recombinant nanobody from camelid single domain antibody fragment with Acinetobacter baumannii.
    Payandeh Z; Rasooli I; Mousavi Gargari SL; Rajabi Bazl M; Ebrahimizadeh W
    Trans R Soc Trop Med Hyg; 2014 Feb; 108(2):92-8. PubMed ID: 24463583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments.
    Arbabi-Ghahroudi M
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NanoBERTa-ASP: predicting nanobody paratope based on a pretrained RoBERTa model.
    Li S; Meng X; Li R; Huang B; Wang X
    BMC Bioinformatics; 2024 Mar; 25(1):122. PubMed ID: 38515052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanobodies as versatile tools: A focus on targeted tumor therapy, tumor imaging and diagnostics.
    Al-Baradie RS
    Hum Antibodies; 2020; 28(4):259-272. PubMed ID: 32831197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in nanobody and its application in diagnosis].
    Kong Q; Yao Y; Chen R; Lu S
    Sheng Wu Gong Cheng Xue Bao; 2014 Sep; 30(9):1351-61. PubMed ID: 25720150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Single-domain antibody - advances in research and application].
    Kang X; Cao J; Zhang B; Yuan Q
    Sheng Wu Gong Cheng Xue Bao; 2018 Dec; 34(12):1974-1984. PubMed ID: 30584708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanobodies: from structure to applications in non-injectable and bispecific biotherapeutic development.
    Li B; Qin X; Mi LZ
    Nanoscale; 2022 May; 14(19):7110-7122. PubMed ID: 35535618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NANOBODIES®: A Review of Diagnostic and Therapeutic Applications.
    Jin BK; Odongo S; Radwanska M; Magez S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Joining the in vitro immunization of alpaca lymphocytes and phage display: rapid and cost effective pipeline for sdAb synthesis.
    Comor L; Dolinska S; Bhide K; Pulzova L; Jiménez-Munguía I; Bencurova E; Flachbartova Z; Potocnakova L; Kanova E; Bhide M
    Microb Cell Fact; 2017 Jan; 16(1):13. PubMed ID: 28114943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural Insights into the Design of Synthetic Nanobody Libraries.
    Valdés-Tresanco MS; Molina-Zapata A; Pose AG; Moreno E
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining of synthetic VHH and immune scFv libraries for pregnancy-associated glycoproteins ELISA development.
    Dormeshkin D; Shapira M; Karputs A; Kavaleuski A; Kuzminski I; Stepanova E; Gilep A
    Appl Microbiol Biotechnol; 2022 Aug; 106(13-16):5093-5103. PubMed ID: 35723693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Easily Established and Multifunctional Synthetic Nanobody Libraries as Research Tools.
    Liu B; Yang D
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and optimization of camelid single-domain antibodies: Dirk Saerens' work on nanobodies.
    Saerens D
    World J Biol Chem; 2010 Jul; 1(7):235-8. PubMed ID: 21537479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.